Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Bear markets test retirement portfolios. This piece explains how risk parity may influence drawdowns and resilience, plus practical steps for retirees.
28,208 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Bitcoin dipped under $63,000 as oil markets steadied and shipping through the Strait of Hormuz resumed. The move come...
Oil prices climb as U.S.-Iran tensions raise the risk of supply disruption through the Strait of Hormuz. Gas prices t...
A volatile session followed reports of tanker attacks in the Persian Gulf, with the VIX surging and oil prices pushin...
Start your week with a curated set of monday reads that translate headlines into practical investing moves. This guid...
U.S. prosecutors in New York investigate links between Colombia's president and drug traffickers, while the DEA desig...
Markets opened with relief and caution as Iran tensions complicated Trump’s bravado. Traders weigh the limits of brin...
A thought experiment about a crypto-friendly kevin warsh confirmed as Fed Chair and the potential ripple effects on c...
SpaceX has filed its S-1 to go public, presenting a three-pronged business plan that could fund a city on Mars. Here ...
Markets react to renewed talks on extending an Iran ceasefire, with potential sanctions relief and Oil-flow changes o...
CME Group has sued the CFTC over how perpetual futures are classified, triggering a formal cftc, request public comme...
Fresh Epstein files are prompting urgent questions about governance and accountability as executives connected to the...